Vol 8 (December 30, 2025): Annals of Esophagus

Definition and treatment strategies for oligometastatic esophageal squamous cell carcinoma (OMESQ): a study protocol for global multidisciplinary consensus using the modified Delphi method

Esophageal metastasis from breast cancer after two decades of remission: a case report

Hepatic vagal branch preservation vs. division during fundoplication: a narrative review

Esophagus-preserving surgery vs. esophagectomy for advanced achalasia: a narrative review

Summary of the updated German national guidelines for gastric cancer and esophagogastric junction cancer v3.0 and narrative review of current developments in treatment

Efficacy, safety, and outcomes for peroral endoscopic myotomy versus laparoscopic Heller myotomy for achalasia: an updated narrative review

Role of immunotherapy in esophageal cancer and its impact on surgical outcomes: a narrative review

The changing face of brain metastasis in esophageal cancer in the current era of multi-modality therapy—literature review

Trends in incidence of esophageal squamous cell carcinoma in the United States between 2001–2021: a United States Cancer Statistics database study

Minimally invasive vs. hybrid esophagectomy: 10-year outcomes from a UK tertiary center

Does a bedtime H₂ blocker still have a role in the era of potassium-competitive acid blockers?

Advancing precision oncology for esophagogastric cancer in the era of antibody-drug conjugates

Pretracheal (No. 106pre) lymph node metastasis, considered an oligometastatic disease, may achieve long-term survival when treated with modern neoadjuvant therapy combined with surgical resection